Fig. 2From: Salvage surgery for advanced non-small cell lung cancer following previous immunotherapy: a retrospective studyPostoperative a DFS and b OS after salvage surgery. The median DFS and median survival time were not reached, and the 2-year DFS and 2-year OS rates were 71.2% and 76.2%, respectivelyBack to article page